<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04103996</url>
  </required_header>
  <id_info>
    <org_study_id>19-5894</org_study_id>
    <nct_id>NCT04103996</nct_id>
  </id_info>
  <brief_title>Incidence, Risk Factors and Outcomes of Diaphragm Dysfunction After Lung Transplantation</brief_title>
  <acronym>RADAR</acronym>
  <official_title>Incidence, Risk Factors and Outcomes of Diaphragm Dysfunction After Lung Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is designed to characterize the changes in diaphragm function after lung&#xD;
      transplantation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diaphragm dysfunction (DD) is a well-known complication after lung transplantation. Patients&#xD;
      with an injured and dysfunctional diaphragm have greater difficulty weaning from mechanical&#xD;
      ventilation post-transplant - they become too weak to breathe. However, little is known about&#xD;
      the pre-transplant predictive factors associated with diaphragm dysfunction . We have&#xD;
      developed a new technique employing beside ultrasound to measure diaphragm thickness. This&#xD;
      allows us to observe changes in diaphragm muscle structure and function.&#xD;
&#xD;
      The goal of the study is to determine whether pre-transplant diaphragm thickness and function&#xD;
      are associated with diaphragmatic dysfunction after lung transplantation. This will help us&#xD;
      to confirm the best way to avoid diaphragm injury and to understanding the meaning of&#xD;
      diaphragm ultrasound images.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 10, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of diaphragm dysfunction at the first spontaneous breathing trial and at ICU discharge after lung transplantation</measure>
    <time_frame>First spontaneous breathing trial, an average of 1 to 7 days</time_frame>
    <description>Diaphragm ultrasound will be used to visualize diaphragm dysfunction (maximal thickening fraction &lt;20%)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pre-transplant diaphragm thickness and function compared to post-transplant diaphragm dysfunction</measure>
    <time_frame>1 day</time_frame>
    <description>Diaphragm thickness and function documented on ultrasound will be assessed</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Diaphragm Injury</condition>
  <condition>Lung Transplant; Complications, Mechanical</condition>
  <condition>Respiratory Failure</condition>
  <condition>Mechanical Ventilation Complication</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Ultrasound</intervention_name>
    <description>Sonographic measurements (diaphragm, abdominal muscle, and quadriceps thickness) will be acquired when listed for lung transplantation. Sonographic measurements will be recorded on a daily basis for up to 1 week after transplantation (while the patient remains intubated).</description>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Respiratory function measurements</intervention_name>
    <description>Maximal expiratory pressure (MEP) and maximal inspiratory pressure (MIP) will be acquired after listing for lung transplantation. After transplant, MIP will be recorded once patients are eligible for a trial of spontaneous breathing and weekly thereafter. MEP will also be recorded at ICU discharge.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        We plan to enroll a total of 100 patients who were listed and will benefit from lung&#xD;
        transplant&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients greater than 18 years of age&#xD;
&#xD;
          -  Listed for lung transplantation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known diagnosis of chronic neuromuscular disease&#xD;
&#xD;
          -  Relisting for transplantation&#xD;
&#xD;
          -  Bridging to lung transplantation with respiratory support&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Toronto General Hospital</name>
      <address>
        <city>Toronto</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>August 27, 2019</study_first_submitted>
  <study_first_submitted_qc>September 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 26, 2019</study_first_posted>
  <last_update_submitted>May 5, 2021</last_update_submitted>
  <last_update_submitted_qc>May 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Health Network, Toronto</investigator_affiliation>
    <investigator_full_name>Ewan Goligher</investigator_full_name>
    <investigator_title>Intensivist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

